Medscheme’s decision to withdraw its lawsuit against Bonitas hands the baton back to the regulator to investigate allegations of tender manipulation and conflicts of interest.
Summary from sourceMedscheme’s decision to withdraw its lawsuit against Bonitas hands the baton back to the regulator to investigate allegations of tender manipulation and conflicts of interest.
Summary from source